IS1994B - Ferli til að smíða fosfódíestera - Google Patents

Ferli til að smíða fosfódíestera

Info

Publication number
IS1994B
IS1994B IS5193A IS5193A IS1994B IS 1994 B IS1994 B IS 1994B IS 5193 A IS5193 A IS 5193A IS 5193 A IS5193 A IS 5193A IS 1994 B IS1994 B IS 1994B
Authority
IS
Iceland
Prior art keywords
phosphodiester
alcohol
reaction
making process
phosphorodichlorodite
Prior art date
Application number
IS5193A
Other languages
English (en)
Other versions
IS5193A (is
Inventor
C. Amedio John
J. Bernard Paul
Fountain Mark
Original Assignee
Epix Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epix Pharmaceuticals, Inc. filed Critical Epix Pharmaceuticals, Inc.
Publication of IS5193A publication Critical patent/IS5193A/is
Publication of IS1994B publication Critical patent/IS1994B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/117Esters of phosphoric acids with cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IS5193A 1997-04-11 1999-09-24 Ferli til að smíða fosfódíestera IS1994B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/833,745 US5919967A (en) 1997-04-11 1997-04-11 Process for synthesizing phosphodiesters
PCT/US1998/001473 WO1998046612A1 (en) 1997-04-11 1998-01-27 Process for synthesizing phosphodiesters

Publications (2)

Publication Number Publication Date
IS5193A IS5193A (is) 1999-09-24
IS1994B true IS1994B (is) 2005-03-15

Family

ID=25265165

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5193A IS1994B (is) 1997-04-11 1999-09-24 Ferli til að smíða fosfódíestera

Country Status (21)

Country Link
US (1) US5919967A (is)
EP (1) EP1021452B1 (is)
JP (2) JP4014231B2 (is)
KR (2) KR100593650B1 (is)
AT (1) ATE236171T1 (is)
AU (1) AU728902B2 (is)
BR (1) BR9809084B1 (is)
CA (1) CA2285417C (is)
CZ (1) CZ294469B6 (is)
DE (1) DE69812983T2 (is)
DK (1) DK1021452T3 (is)
ES (1) ES2195315T3 (is)
HU (1) HU224257B1 (is)
IL (1) IL131964A (is)
IS (1) IS1994B (is)
NO (1) NO325619B1 (is)
NZ (1) NZ337921A (is)
PL (1) PL188258B1 (is)
PT (1) PT1021452E (is)
SK (1) SK283832B6 (is)
WO (1) WO1998046612A1 (is)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1019094B1 (en) 1997-10-02 2003-11-19 Epix Medical, Inc. Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
US6559330B1 (en) * 1999-09-09 2003-05-06 Schering Aktiengesellschaft Calcium complex of [[(4r)-4-[bis{carboxy-.kappa.o)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.o)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.n6,.kappa.n9,.kappa.011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
DE19964224B4 (de) * 1999-09-09 2005-09-01 Schering Ag Pharmazeutische Mittel enthaltend Calcium-Komplex von [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.N]-6,9-bis[(carboxy-.kappa.O)methyl]-1-[(4,4-diphenylcyclohexyl)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-yl-säure-.kappa.N6,.kappa.N9,.kappa.011]1-oxidato(6-)]-, tetrahydrogen (MS-325) und dessen Salze sowie Verfahren zur Herstellung der Mittel
US20030203879A1 (en) * 1999-09-09 2003-10-30 Schering Ag Calcium complex of [[(4R)-4-[bis[(carboxy-.kappa.O)methyl]amino-.kappa.n]-6,9-bis[(carboxy.kappa.O)methyl]-1-[(4,4-diphenylcyclohexy)oxy]-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan-11-ylic-acid-.kappa.N6,.Kappa.N9,.Kappa 011]1-oxidato(6-)]-, hexahydrogen, its salts, pharmaceutical agents that contain these complexes, their use in treatment and as additives in diagnosis, as well as processes for the production of the complexes and agents
WO2003029257A1 (de) * 2001-09-27 2003-04-10 Schering Aktiengesellschaft (ethylen)-(propylen/butylen)-phosphodiester-triaminpentaessigsäure-derivate
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
ES2506142T3 (es) 2002-03-01 2014-10-13 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
WO2004065621A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
EP1603935A4 (en) 2003-03-03 2007-03-21 Dyax Corp SPECIFIC TO HGF RECEPTOR (cMET) BINDING PEPTIDES AND THEIR USE
KR100585219B1 (ko) * 2004-05-07 2006-06-01 주식회사 태평양 포스페이트 유도체 및 이의 제조방법
CN100487093C (zh) * 2006-03-15 2009-05-13 中国石油化工股份有限公司 一种亚磷酰胺酯类极压抗磨剂及其制备和应用
AR075900A1 (es) 2009-03-19 2011-05-04 Wyeth Llc Metodos para la preparacion de acidos (2-(8,9-dioxo-2,6-diazabiciclico (5.2.0) non-1(7)-en-2-il)etil) fosfonico y sus precursores.
WO2010121133A2 (en) 2009-04-17 2010-10-21 The General Hospital Corporation Multimodal imaging of fibrin
TW201514188A (zh) * 2013-03-13 2015-04-16 Lantheus Medical Imaging Inc 製備釓磷維塞三鈉單水合物之方法
WO2015171543A1 (en) 2014-05-05 2015-11-12 California Institute Of Technology Mutant akt-specific capture agents, compositions, and methods of using and making
US10471162B2 (en) 2014-06-20 2019-11-12 The General Hospital Corporation Collagen targeted imaging probes
EP3270951B1 (en) 2015-03-16 2020-09-09 California Institute of Technology Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
CN108290927B (zh) 2015-07-15 2022-06-24 加州理工学院 Il-17f-特异性捕获剂、组合物以及使用和制造的方法
US11884707B2 (en) 2016-09-29 2024-01-30 Regeneron Pharmaceuticals, Inc. Compositions for detection, inhibition and imaging of indoleamine 2, 3-dioxygenase 1 (IDO1) and methods of making and using same
US11358982B2 (en) 2016-11-01 2022-06-14 Ohio State Innovation Foundation Methods for the iodination of biomolecules
WO2018232345A1 (en) 2017-06-15 2018-12-20 Indi Molecular, Inc. Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
WO2020093055A2 (en) 2018-11-02 2020-05-07 Indi Molecular, Inc. Peptide libraries with non-canonical amino acids
WO2020097531A1 (en) 2018-11-08 2020-05-14 Indi Molecular, Inc. Theranostic capture agents, compositions, and methods of using and making
US11414460B2 (en) 2019-07-19 2022-08-16 Institute For Systems Biology KRAS-specific capture agents, compositions, and methods of making and using
WO2022098743A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
WO2022098745A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, delivery systems, and methods useful in tumor therapy
JPWO2022185843A1 (is) * 2021-03-03 2022-09-09

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4880008A (en) * 1985-05-08 1989-11-14 The General Hospital Corporation Vivo enhancement of NMR relaxivity
TW319763B (is) * 1995-02-01 1997-11-11 Epix Medical Inc
AU717099B2 (en) * 1995-03-08 2000-03-16 Scripps Research Institute, The Carbopeptoids and carbonucleotoids

Also Published As

Publication number Publication date
DK1021452T3 (da) 2003-08-18
BR9809084A (pt) 2000-08-01
AU6042598A (en) 1998-11-11
KR100593650B1 (ko) 2006-07-03
IS5193A (is) 1999-09-24
DE69812983D1 (de) 2003-05-08
JP4014231B2 (ja) 2007-11-28
NZ337921A (en) 2000-09-29
SK283832B6 (sk) 2004-02-03
NO325619B1 (no) 2008-06-30
EP1021452A1 (en) 2000-07-26
JP2002511060A (ja) 2002-04-09
WO1998046612A1 (en) 1998-10-22
CZ294469B6 (cs) 2005-01-12
NO994919D0 (no) 1999-10-08
AU728902B2 (en) 2001-01-18
KR20060066122A (ko) 2006-06-15
EP1021452B1 (en) 2003-04-02
PL188258B1 (pl) 2005-01-31
IL131964A (en) 2004-01-04
US5919967A (en) 1999-07-06
HU224257B1 (hu) 2005-07-28
HUP0004239A2 (en) 2001-03-28
HUP0004239A3 (en) 2001-11-28
CZ355999A3 (cs) 2000-01-12
ES2195315T3 (es) 2003-12-01
ATE236171T1 (de) 2003-04-15
JP2005206605A (ja) 2005-08-04
PT1021452E (pt) 2003-08-29
IL131964A0 (en) 2001-03-19
SK138299A3 (en) 2000-05-16
CA2285417C (en) 2006-01-24
NO994919L (no) 1999-10-08
PL337423A1 (en) 2000-08-14
KR20010006177A (ko) 2001-01-26
BR9809084B1 (pt) 2010-12-14
DE69812983T2 (de) 2004-01-08
CA2285417A1 (en) 1998-10-22

Similar Documents

Publication Publication Date Title
IS1994B (is) Ferli til að smíða fosfódíestera
BR9807568A (pt) Processo para a produção de ácido 4-amino-1-hidroxibutilideno-1
WO2002006279A8 (en) Efficient method of synthesizing combretastatin a-4 prodrugs
ATE141278T1 (de) Diphosphonsaurederivate als zwischenprodukte zur herstellung von diphosphinliganden
ATE377015T1 (de) Verbessertes verfahren zur phosphorylierung
EP0675076A3 (en) Phosphorylation reagent, method and use.
FI883207A (fi) Foerfarande foer framstaellning av aminometylenfosfonoalkylfosfinater.
ES8500284A1 (es) Procedimiento para preparar n-fosfonometilglicina.
HUT45541A (en) Plant protecting compositions containing ester of phosphoric acid as active component and process for producing the active component
ES382819A1 (es) Procedimiento para la obtencion de esteres de acidos tria- zolo-tiazol (tiono)-fosforicos-fosfonicos y fosfinicos.
DK0693074T3 (da) Fremgangsmåde til fremstilling af aminomethanphosphonsyre
GB1514099A (en) Thymol blue monophosphate salts and diagnostic method using same
JPS53144558A (en) Color protection of beta-naphthol
JPS57183796A (en) Preparation of organophosphoric acid ester substituted with alkylsulfinyl group
ES2127876T3 (es) Acidos fosforicos sustituidos.
ES463860A1 (es) Procedimiento para preparar anhidridos de acidos organofos- foricos
ES460183A1 (es) Procedimiento para la obtencion de amidas-esteres o-(1-fluo-ro-2-halogeno-etilicos) de los acidos (tiono)-fosfo-ricos (-nicos).
JPS56166197A (en) O-alkyl s-alkyl or -aryl thiophosphoric chloride